Legal & General Global Health and Pharmaceuticals Index Trust

Select share classes

Legal & General Global Health & Pharmaceuticals Index Trust I Class Accumulation

Category Sector Equity Healthcare

star-filledstar-filledstar-filledstar-filled
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price

118.20p

arrow-up1.00p (+0.85%)

Fund Code

LGGPA

B0CNH38

GB00B0CNH387

Prices updated as at 09 May 2025
|
Prices in GBX

Investment objective
The objective of the Fund is to track the performance of the FTSE World Index - Health Care (the “Benchmark Index”) on a net total return basis before fees and expenses are applied. Therefore, the Fund’s performance may differ from the Benchmark Index due to the deduction of fees and expenses and the impact of any tracking error factors. The Benchmark Index is comprised of shares in companies engaged in health, pharmaceuticals and biotechnology. The Fund is a Replicating Fund as it seeks to replicate as closely as possible the constituents of the Benchmark Index by holding all, or substantially all, of the assets comprising the Benchmark Index in similar proportions to their weightings in the Benchmark Index. The Fund will have at least 90% exposure to assets that are included in the Benchmark Index.

Portfolio as of 31/03/2025

Asset allocation

Created with Highcharts 7.2.299.08% Stocks- Bonds0.92% Cash0% Other- Not classified
Show long & short position

Geographical breakdown

Continent or country allocation (%)

Created with Highcharts 7.2.20.730.730.790.791.721.724.164.164.874.875.185.1812.1112.1169.9969.99Asia - EmergingAsia - DevelopedAustralasiaJapanUnited KingdomEurozoneEurope - ex EuroUnited States

Market classification (%)

Created with Highcharts 7.2.20.950.9599.0599.05EmergingDeveloped

Stock style

Large value

41.38%

% Weight
Value
Core
Growth
Large

41

20

25

Medium

3

6

3

Small

0

0

0

Valuation

Legal & General Global Health & Pharmaceuticals Index Trust I Class Accumulation
Sector Equity Healthcare

17.24

17.24
19.46

2.25

2.25
1.89

4.03

4.03
4.28

14.67

14.67
16.54

Growth rate

Legal & General Global Health & Pharmaceuticals Index Trust I Class Accumulation
Sector Equity Healthcare

9.81%

9.81%
10.42%

1.94%

1.94%
1.36%

2.05%

2.05%
2.10%

Top 10 holdings

Security nameSectorCountry% of assets
1Eli Lilly and Co-United States8.67
2UnitedHealth Group Inc-United States6.48
3Johnson & Johnson-United States5.38
4AbbVie Inc-United States4.91
5Roche Holding AG-Switzerland3.15
6Abbott Laboratories-United States3.08
7Merck & Co Inc-United States3.04
8Novartis AG Registered Shares-Switzerland2.97
9Novo Nordisk AS Class B-Denmark2.92
10AstraZeneca PLC-United Kingdom2.55
Assets in top 10 holdings %

43.15%

Total no. of equity holdings

177.00

Total no. of bond holdings

-

Stock sectors

Legal & General Global Health & Pharmaceuticals Index Trust I Class Accumulation
Sector Equity Healthcare

0.34%

Basic materials

0.31%
-

Con cyclical

-
-

Financial svs

0.03%
-

Real estate

-
-

0.00%

Comm services

-
-

Energy

-
-

Industrials

-
-

Technology

-
-

99.66%

Con defensive

0.04%
-

Healthcare

99.62%
-

Utilities

-
-


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.